Skip to content
  • Sunday, 26 July 2026
  • 12:51 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • European Commission Approves Expanded Use of Crysvita (burosumab) for Infants with X-Linked Hypophosphatemia
Pharmaceutical R&D

European Commission Approves Expanded Use of Crysvita (burosumab) for Infants with X-Linked Hypophosphatemia

Teuku Ryan Jul 23, 2026 0

Kyowa Kirin EMEA, a subsidiary of Kyowa Kirin, has secured a significant approval from the European Commission (EC) to broaden…

Read More
Pharmaceutical R&D

Novo Nordisk Secures European Approval for Oral Wegovy, Bolstering First-Mover Advantage in Obesity Pill Market

Teuku Ryan Jul 20, 2026 0

Novo Nordisk has solidified its pioneering position in the burgeoning market for oral obesity medications with the European Commission’s marketing…

Read More
Pharmaceutical R&D

European Commission Approves AbbVie’s Aquipta (atogepant) for Acute Migraine Treatment

Teuku Ryan Jun 3, 2026 0

AbbVie has secured a significant regulatory endorsement from the European Commission (EC) for Aquipta (atogepant), marking a pivotal expansion of…

Read More
Pharmaceutical R&D

Novo Nordisk’s Wegovy Poised for Significant European Expansion Following Positive CHMP Opinions on Oral and High-Dose Injectable Formulations

Teuku Ryan May 27, 2026 0

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…

Read More
Biotech & Genetic Research

Insights from Millennium Technology Prize Panel Illuminate European Biotech Strengths and Strategic Imperatives

Jia Lissa May 26, 2026 0

A recent high-level panel discussion, convened by the Technology Academy Finland (TAF) at the Finnish Ambassador’s residence in London, brought…

Read More
Biotech & Genetic Research

European Biotech Leaders Chart Course for Innovation, Urge Risk-Taking and Long-Term Commitment at Millennium Technology Prize Panel

Jia Lissa May 19, 2026 0

A recent high-level panel discussion, convened by the Technology Academy Finland (TAF) and hosted at the residence of the Finnish…

Read More
Advanced Materials Science

Scientists Map Ultra-Fast Plasma Formation with Femtosecond Precision at European XFEL

Nila Kartika Wati May 18, 2026 0

The pursuit of clean, limitless energy through nuclear fusion and the understanding of the most violent phenomena in the universe…

Read More
Pharmaceutical R&D

Tirzepatide Shows Promising Adjunct Benefits in Type 1 Diabetes Management, Meta-Analysis Presented at European Congress on Obesity Suggests

Teuku Ryan May 16, 2026 0

The burgeoning field of GLP-1 receptor agonists, celebrated for their transformative impact on obesity and type 2 diabetes (T2D) management,…

Read More
Advanced Materials Science

Capturing the Chaos: HZDR Researchers Unveil the Picosecond Evolution of Laser-Induced Plasma at European XFEL

Nila Kartika Wati May 11, 2026 0

In the realm of high-energy density physics, the transition of solid matter into plasma occurs with such violent speed and…

Read More
Neuroscience & Brain Research

Loneliness Linked to Lower Baseline Memory in Older Adults but Does Not Accelerate Long-Term Cognitive Decline According to Large European Study

Rifan Muazin Apr 29, 2026 0

A comprehensive longitudinal study involving more than 10,000 participants across Europe has revealed a complex relationship between subjective feelings of…

Read More

Posts pagination

1 2
How the Human Brain Separates Content and Context to Form Memories: A Study from the University of BonnMolecular Switch Discovery Enhances Blood Stem Cell Activation for Advanced Bone Marrow Transplants and Gene TherapiesNorthwestern University Research Unveils Neurobiological Secrets of SuperAgers Defying Cognitive DeclineResearchers Develop Novel Vitamin K Analogues as Potential Regenerative Therapy for Neurodegenerative Diseases
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ